China Lactic Acid and Derivative Industry Report, 2013
  • Aug./2013
  • Hard Copy
  • USD $1,800
  • Pages:57
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: LT005
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,700
  • Hard Copy + Single User License
  • USD $2,000
China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their designed annual capacity with a high idle capacity rate. In 2010-2011, China’s idle annual capacity of lactic acid reached at least 110,000 tons. The capacity and output in 2012 were estimated to be 329,000 tons and 226,000 tons respectively, up 15% and 28.4% separately from 2011.

Henan Jindan Lactic Acid Technology and Chongqing Bofei Biochemical Products possess the largest lactic acid capacity in China. In 2012, their combined capacity of the two totaled 175,000 tons, equivalent to 53.2% of China’s total lactic acid capacity. Each of other lactic acid enterprises seizes the capacity of 10,000-30,000 tons averagely.

China’s Lactic Acid Capacity and Output, 2006-2012

In China, the food and beverage industry is accustomed to use lactic acid in condiments, liquor brewery industry, milk processing and others. In 2012, the food and beverage industry consumed about 161,000 tons of lactic acid, accounting for 49.2% of China's total lactic acid consumption; 119,000 tons of lactic acid (36.1%) was applied to leather manufacturing, microelectronics, electroplating industry, polylactic acid production and other industrial fields.

By virtue of pollution-free, degradability and alternative properties (polylactic acid can replace petroleum-based materials excellently), polylactic acid has become one of the most potential derivatives in China lactic acid industry. With the completion of the technological transformation of most polylactic acid manufacturers and the operation of new production lines, China’s polylactic acid capacity reached 85,500-102,000 tons in 2012. As a giant in China polylactic acid industry, Hisun Biomaterials attained the polylactic acid capacity of approximately 30,000 tons in 2012 and it is building one 20,000 t / a polylactic acid project.

 The report covers the followings:

20120114.gif Competition pattern, market supply and demand and outlook of the global lactic acid and derivative industry;
20120114.gif Market supply and demand, competition pattern, outlook, and polylactic acid application prospect of China lactic acid and derivative industry;
20120114.gif Import and export of Chinese lactic acid and derivatives including polylactic acid, lactic acid, lactate salt and lactic ester ;
20120114.gif Operation of global lactic acid and derivative companies PURAC, GALACTIC, ADM and Cargill;
20120114.gif Operation of 15 Chinese lactic acid and derivative enterprises (including Hisun Biomaterials, COFCO Biochemical GALACTIC, Jindan Lactic Acid, Hypow Biotechnology, Bofei Biochemical Products, Kaifeng Bioengineering, Haijianuo Biological Engineering and Sanjiang Space Good Biotech).

1 Introduction to Lactic Acid and Derivatives
1.1 Definition of Lactic Acid
1.2 Chinese Industrial Policies about Lactic Acid and Derivatives
1.2.1 Lactic Acid
1.2.2 Polylactic Acid

2 Development of Global Lactic Acid and Derivative Industry 
2.1 Competition Pattern 
2.2 Market Supply and Demand 
2.3 Outlook 

3 Development of China Lactic Acid and Derivative Industry
3.1 Market Supply and Demand 
3.2 Competition Pattern 
3.3 Outlook 
3.4 Application Prospect of Polylactic Acid  
3.4.1 Pharmaceutical Field
3.4.2 Others

4 Polylactic Acid Import and Export in China
4.1 Polylactic Acid
4.2 Lactic Acid, Lactate Salt and Lactic Ester 

5 Major Lactic Acid and Derivative Companies in the World
5.1 PURAC 
5.1.1 Profile
5.1.2 Production 
5.1.3 Operation 
5.2.1 Profile
5.2.2 Development Course 
5.2.3 Operation 
5.3 ADM
5.3.1 Profile
5.3.2 Operation 
5.4 Cargill 
5.4.1 Profile
5.4.2 Lactic Acid Business 

6 Major Lactic Acid and Derivative Enterprises in China
6.1 Zhejiang Hisun Biomaterials 
6.1.1 Profile
6.1.2 Main Products 
6.1.3 Polylactic Acid Business 
6.2 Anhui COFCO Biochemical & GALACTIC 
6.2.1 Profile
6.2.2 Main Products 
6.2.3 Operation 
6.3 Henan Jindan Lactic Acid Technology
6.3.1 Profile
6.3.2 Main Products 
6.3.3 Operation 
6.3.4 R & D and Investment 
6.4 Ningxia Hypow Biotechnology 
6.4.1 Profile
6.4.2 Main Products 
6.4.3 Operation 
6.5 Chongqing Bofei Biochemical Products 
6.5.1 Profile
6.5.2 Main Products 
6.5.3 Operation 
6.6 Xiaogan Kaifeng Bioengineering    
6.6.1 Profile
6.6.2 Main Products 
6.6.3 Operation 
6.7 Yancheng Haijianuo Biological Engineering  
6.7.1 Profile
6.7.2 Main Products 
6.7.3 Operation 
6.8 Wuhan Sanjiang Space Good Biotech  
6.8.1 Profile
6.8.2 Main Products 
6.9 Other Lactic Acid and Derivative Enterprises in China
6.9.1 Shanxi Leda Biochemical    
6.9.2 Shengnongli (Huludao) Biotechnology  
6.9.3 Hunan Anhua Lactic Acid Plant
6.9.4 Musashino Chemical (China) 
6.9.5 Shenzhen Esun Industrial   
6.9.6 Nantong Jiuding Biological Engineering 
6.9.7 Yangtze Labre  
Main Lactic Acid Derivatives and Applications
Policies on Polylactic Acid Industry in China
Capacity of Major Global Lactic Acid Manufacturers, 2012
Capacity of Major Global Polylactic Acid Manufacturers, 2012
Market Share of Global Polylactic Acid Manufacturers, 2012
Consumption Structure of Global Lactic Acid (by Region), 2012
Global Polylactic Acid Capacity Distribution (by Industry), 2011
Global Polylactic Acid Output Value (by Region), 2009-2011
Global Polylactic Acid Output Value (by Region), 2012-2016E
Global Polylactic Acid Capacity, 2011-2020E
Global Lactic Acid Demand, 2010-2016E
Lactic Acid Capacity and Output in China, 2006-2012
Capacity of Major Lactic Acid Manufacturers in China, 2012
Lactic Acid Consumption Structure in China, 2012
Weekly Average Lactic Acid Price in Shanghai Zhongshan Chemical Market, 2007-Jul 2013
Market Share of Chinese Lactic Acid Enterprises, 2012
Capacity of Major Polylactic Acid Manufacturers in China, 2008 vs 2012
China’s Lactic Acid Capacity, 2013-2016E
Demand for Implantable Biomedical Products in China, 2011
Import Volume and Value of Polylactic Acid in China, 2007- Jun. 2013
Top 10 Countries of Origin by Import Volume of Polylactic Acid in China, Jan-Jun 2013
Polylactic Acid Export Volume and Value in China, 2009-Jun. 2013
Top 10 Export Destinations of Chinese Polylactic Acid, Jan-Jun., 2013
Import Volume and Value of Lactic Acid, Lactate Salt and Lactic Ester in China, 2010- Jun. 2013
Top 10 Ports by Import Volume of Lactic Acid, Lactate Salt and Lactic Ester in China, Jan-Jun., 2013
Export Volume and Value of Lactic Acid, Lactate Salt and Lactic Ester in China, 2010-Jun. 2013
Top 10 Ports by Export Volume of Lactic Acid, Lactate Salt and Lactic Ester in China, Jan-Jun., 2013
Main Products and Business Scope of PURAC
PURAC's Production Plants
Distribution of PURAC's Plants and Sales Offices
Revenue and EBIT of PURAC, 2008-2015E
Revenue Structure of PURAC (by Sector), 2011
Capital Expenditure and Return on Investment of PURAC, 2009-2012
Main Products of GALACTIC
Development Course of GALACTIC
Net Income and Growth Rate of GALACTIC, 2008-2012
Main Lactic Acid Products of ADM
Net Sales and Net Income of ADM, 2009-2011
Business Models of ADM
Global Distribution of ADM
Main Products of Cargill
Production Modes of Ingeo
Development of NatureWorks by Country, 2010-2011 
Main Products of Hisun Biomaterials
Polylactic Acid Capacity Development Course of Hisun Biomaterials
Products of COFCO Biochemical & GALACTIC 
Revenue and Net Profit Margin of COFCO Biochemical & GALACTIC, 2009-2012      
Operating Cost and Gross Margin of COFCO Biochemical & GALACTIC, 2009-2012         
Products of Jindan Lactic Acid
Revenue of Jindan Lactic Acid, 2010-2012 
Products of 50,000 t/a Polylactic Acid Project of Jindan Lactic Acid 
Average Annual Consumption of Raw Materials of 50,000 t/a Polylactic Acid Project of Jindan Lactic Acid 
Organizational Structure of Hypow Biotechnology
Main Lactic Acid Products of Hypow Biotechnology
Sales Network of Hypow Biotechnology  
Main Products of Bofei Biochemical Products
Sales Network of Bofei Biochemical Products  
Main Products of Kaifeng Bioengineering
Main Products of Haijianuo Biological Engineering
Sales Revenue of Haijianuo Biological Engineering, 2010-2015E
Main Products of Sanjiang Space Good Biotech
Main Products of Shanxi Leda Biochemical
Development Course of Musashino Chemical (China)
Branches of Shenzhen Esun Industrial 
Main Products of Nantong Jiuding Biological Engineering
Main Polylactic Acid Fiber Products of Yangtze Labre

China Animal Vaccine Industry Report, 2019-2025

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized ba...

China Blood Product Industry Report, 2020-2026

With the dynamic adjustment in the catalog of medicines covered by national medical insurance system, the scope of clinical use of almost all blood products grows tremendously, so does the reimburseme...

China Vacuum Blood Collection Device Industry Report, 2019-2025

As laboratory medicine advances, favorable polices are issued and people live a better life and care more about their health, vacuum blood collection systems get increasingly used. In 2018, global vac...

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号